AMPD2 Gene Pontocerebellar Hypoplasia Type 9 Genetic Test
Test Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information:
A Genetic Counselling session to draw a pedigree chart of family members affected with AMPD2 Gene Pontocerebellar Hypoplasia, type 9.
Test Details:
Pontocerebellar hypoplasia, type 9 (PCH9) is a rare genetic disorder characterized by underdevelopment (hypoplasia) of the pons and cerebellum, which are parts of the brain involved in coordinating movement and balance. It is caused by mutations in the AMPD2 gene.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of PCH9, NGS genetic testing can be used to identify mutations in the AMPD2 gene that are responsible for the condition. By analyzing the entire coding region of the AMPD2 gene, NGS genetic testing can provide a comprehensive assessment of genetic variations that may be present. This can help in confirming a diagnosis of PCH9 and determining the specific mutation responsible for the condition.
NGS genetic testing is typically performed using a blood sample or other tissue samples from the affected individual. The sample is then sequenced using NGS technology, and the resulting data is analyzed to identify any genetic variations in the AMPD2 gene.
The information obtained from NGS genetic testing can be used for genetic counseling, family planning, and potentially for developing personalized treatment strategies in the future. It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals who specialize in genetics.
Test Name | AMPD2 Gene Pontocerebellar hypoplasia type 9 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AMPD2 Gene Pontocerebellar hypoplasia, type 9 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AMPD2 Gene Pontocerebellar hypoplasia, type 9 |
Test Details |
Pontocerebellar hypoplasia, type 9 (PCH9) is a rare genetic disorder characterized by underdevelopment (hypoplasia) of the pons and cerebellum, which are parts of the brain involved in coordinating movement and balance. It is caused by mutations in the AMPD2 gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of PCH9, NGS genetic testing can be used to identify mutations in the AMPD2 gene that are responsible for the condition. By analyzing the entire coding region of the AMPD2 gene, NGS genetic testing can provide a comprehensive assessment of genetic variations that may be present. This can help in confirming a diagnosis of PCH9 and determining the specific mutation responsible for the condition. NGS genetic testing is typically performed using a blood sample or other tissue samples from the affected individual. The sample is then sequenced using NGS technology, and the resulting data is analyzed to identify any genetic variations in the AMPD2 gene. The information obtained from NGS genetic testing can be used for genetic counseling, family planning, and potentially for developing personalized treatment strategies in the future. It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals who specialize in genetics. |